These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6265849)

  • 21. Stimulation of rat liver microsomal cGMP-inhibited cAMP phosphodiesterase (PDE III) by phospholipase C and D.
    Carpenedo F; Floreani M
    Biochem Biophys Res Commun; 1993 Jan; 190(2):609-15. PubMed ID: 8381282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Determination of the lecithinase activity of thermoresistant strains of Clostridium perfringens].
    Keleti J; Rusinko M
    Cesk Epidemiol Mikrobiol Imunol; 1966 Jul; 15(4):209-13. PubMed ID: 4288832
    [No Abstract]   [Full Text] [Related]  

  • 23. Bacterial phospholipases and their role in virulence.
    Songer JG
    Trends Microbiol; 1997 Apr; 5(4):156-61. PubMed ID: 9141190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjugated polyelectrolyte based real-time fluorescence assay for phospholipase C.
    Liu Y; Ogawa K; Schanze KS
    Anal Chem; 2008 Jan; 80(1):150-8. PubMed ID: 18044959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diether phosphinate lecithin: chemical synthesis and effects on phospholipase C.
    Rosenthal AF; Chodsky SV; Han SC
    Biochim Biophys Acta; 1969 Oct; 187(3):385-92. PubMed ID: 4310716
    [No Abstract]   [Full Text] [Related]  

  • 26. [Zinc as a metal cofactor of lecithinase C of Clostridium perfringens].
    Ispolatovskaia MV
    Dokl Akad Nauk SSSR; 1967 Apr; 173(6):1445-7. PubMed ID: 4315703
    [No Abstract]   [Full Text] [Related]  

  • 27. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.
    Schoepe H; Pache C; Neubauer A; Potschka H; Schlapp T; Wieler LH; Baljer G
    Infect Immun; 2001 Nov; 69(11):7194-6. PubMed ID: 11598102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of phospholipase C by isosteric phosphinic acid analogues of lecithin.
    Rosenthal AF; Chodsky SV
    Lipids; 1974 Feb; 9(2):77-80. PubMed ID: 4361140
    [No Abstract]   [Full Text] [Related]  

  • 29. [Some characteristics of proteolytic systems of Cl. perfringens type A].
    Tel'bukh VP; Blagoveshchenskiĭ VA; Ispolatovskaia MV; Borishpolets ZI
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Dec; 48(12):93-7. PubMed ID: 4332196
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effects of various chemical compounds on the lecithinase of C1. perfringens].
    Ispolatovskaia MV; Klimacheva LV
    Biokhimiia; 1966; 31(3):491-500. PubMed ID: 4299361
    [No Abstract]   [Full Text] [Related]  

  • 31. Crystal structure of the C. perfringens alpha-toxin with the active site closed by a flexible loop region.
    Eaton JT; Naylor CE; Howells AM; Moss DS; Titball RW; Basak AK
    J Mol Biol; 2002 May; 319(2):275-81. PubMed ID: 12051905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter upstream bent DNA activates the transcription of the Clostridium perfringens phospholipase C gene in a low temperature-dependent manner.
    Katayama S; Matsushita O; Jung CM; Minami J; Okabe A
    EMBO J; 1999 Jun; 18(12):3442-50. PubMed ID: 10369683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of residues in the carboxy-terminal domain of Clostridium perfringens alpha-toxin (phospholipase C) which are required for its biological activities.
    Walker N; Holley J; Naylor CE; Flores-Díaz M; Alape-Girón A; Carter G; Carr FJ; Thelestam M; Keyte M; Moss DS; Basak AK; Miller J; Titball RW
    Arch Biochem Biophys; 2000 Dec; 384(1):24-30. PubMed ID: 11147832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of phospholipase.
    Blackwell GJ; Flower RJ
    Br Med Bull; 1983 Jul; 39(3):260-4. PubMed ID: 6354351
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin.
    Schoepe H; Neubauer A; Schlapp T; Wieler LH; Baljer G
    Anaerobe; 2006 Feb; 12(1):44-8. PubMed ID: 16701610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-Nitrocoumarin is an efficient inhibitor of budding yeast phospholipase-C.
    Tisi R; Coccetti P; Banfi S; Martegani E
    Cell Biochem Funct; 2001 Dec; 19(4):229-35. PubMed ID: 11746203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Phospholipase C inhibitor].
    Homma Y; Homma M
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1611-7. PubMed ID: 9309162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification, crystallization and preliminary X-ray diffraction studies of alpha-toxin of Clostridium perfringens.
    Basak AK; Stuart DI; Nikura T; Bishop DH; Kelly DC; Fearn A; Titball RW
    J Mol Biol; 1994 Dec; 244(5):648-50. PubMed ID: 7990145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro inhibitory effect of hen egg white lysozyme on Clostridium perfringens type A associated with broiler necrotic enteritis and its alpha-toxin production.
    Zhang G; Darius S; Smith SR; Ritchie SJ
    Lett Appl Microbiol; 2006 Feb; 42(2):138-43. PubMed ID: 16441378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C.
    Parker SL; Parker MS; Sweatman T; Crowley WR
    J Pharmacol Exp Ther; 1998 Jul; 286(1):382-91. PubMed ID: 9655883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.